Alcabes P, Friedland G. Injection drug use and human immunodeficiency virus infection. Clin Infect Dis 1995;20:1467-79.

Alter M. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993;2:155-66.

Auerbach JD, Wypijewska C, Brodie KH, editors. AIDS and behavior: an integrated approach. Washington, DC: National Academy Press; 1994.

Ball JC, Ross A. The effectivenesss of methadone maintenance treatment. New York: Springer Verlag; 1991.

Bandura A. Social cognitive theory and exercise of control over HIV infection. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: Theories and methods of behavioral interventions. New York: Plenum; 1994. p. 25-9.

Battjes RJ, Pickens RW, Brown LS. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update. J Acquir Immune Defic Syndr Hum Retrovirology 1995;10:90-6.

Binson D, Michaels S, Stall R, Coates TJ, Gagnon JH, Catania JA. Prevalence and social distribution of men who have sex with men: United Stated and its urban centers. J Sex Res 1995;32:245-54.

Brookmeyer R, Gail MH. Risk factors for infection and the probability of HIV transmission. In: AIDS epidemiology: a quantitative approach. New York: Oxford University Press; 1994. p. 19-50.

Bruneau J, Lamothe FE, Lachance N, et al. Increased HIV seroprevalence and seroincidence associated with participation in needle exchange program: unexpected findings from Saint-Luc Cohort Study in Montreal. Paper presented at: XI International Conference on AIDS; 1996 Jul 9; Vancouver, Canada.

Bunning BC. Effects of Amsterdam needle and syringe exchange. Int J Addict 1991;26:1303-11.

Caplehorn JRM, Ross MW. Methadone maintenance and the likelihood of risky needle sharing. Int J Addict 1995;30:685-98.

Centers for Disease Control and Prevention. Community-level prevention of human immunodeficiency virus infection among high-risk populations: the AIDS Communit y Demonstration projects. MMWR Morb Mortal Weekly Rep 1996;45 (RR-6).

Choi KH, Catania JA. Changes in multiple partnerships, HIV testing, and condom use among U.S. heterosexuals 18 to 49 years of age, 1990 and 1992. Am J Public Health 1996;86:554-6.

Coates TJ, Gutzwiller F, Des Jarlais D, Kippax S, Schechter M, van den Hoek JAR. HIV prevention in developed countries. Lancet 1996;348:1143-8.

Coates TJ, Chesney M, Folkman S, et al. Designing behavioural and social science research to impact practice and policy in HIV prevention and care. Int J STD and AIDS 1996;7(Suppl. 2):2-12.

de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331:341-6.

Des Jarlais DC, Friedmann P, Hagan H, Friedman SR. Protective effect of AIDS-related behavior change among injection drug users: a cross national study. Am J Public Health 1996;86:1780-5.

Des Jarlais DC. HIV incidence among injecting drug users in New York City Syringe-Exchange Programmes. Lancet 1996;348:987-91.

Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992;6(10):1053-68.

Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A, Ross M, Purchase D, Millson ME, Myergs T. Maintaining low HIV seroprevalence in populations of infecting drug users. JAMA 1995;274(15):1226-31.

Dubois-Arber F, Jeannin A, Konings E, Paccaud F. AIDS prevention: trend analysis shows evidence of increase in condom use without other major changes in sexual behavior among the general population in Switzerland. Am J Public Health. In press.

Ehrhardt AA. Sexual behavior among heterosexuals. In: Mann J, Tarantola D, editors. AIDS in the world II. New York, Oxford: Oxford University Press; 1996. p. 259-63.

Ehrhardt AA, Exner TM, Seal D. A review of HIV interventions for at-risk women, HIV Center for Clinical and Behavioral studies, New York State Psychiatric Institute and Columbia University, New York, NY. Unpublished contractor report prepared for the Office of Technology Assessment: The effectiveness of AIDS prevention efforts. Washington, DC: U.S. Congress; September 1995.

Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol 1993;17(S-3):S67-71.

Fishbein M, Bandura A, Triandis HC, Kanfer FH, Becker MH, Middlestadt SE, Eichler A. Factors influencing behavior and behavior change: final report-theorist's workshop. Rockville, MD: NIMH; 1992. [A slightly revised version of this report will be published in Baum A, Revenson T, Singer J, editors. Handbook of health psychology. New Jersey: Lawrence Erlbaum and Associates.]

Fishbein M, Middlestadt SE, Hitchcock PJ. Using information to change sexually transmitted disease-related behaviors: an analysis based on the theory of reasoned action. In Wasserheit JN, Aral SO, Holmes KK, editors. Research issues in human behavior and sexually transmitted diseases in the AIDS era. Washington, DC: American Society for Microbiology; 1991. p. 243-57.

Gibson DR, Wermuth L, Lovelle-Drache J, Ham J, et al. Brief counseling to reduce AIDS risk in intravenous drug users and their sexual partners: preliminary results. Counseling Psychol Q 1989;2(1):15-9.

Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 1995;346:530-6.

Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter JJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1994;85:1531-7.

Hobfoll SE, Jackson AP, Lavin J, Britton PJ, Shepherd JB. Women's barriers to safe sex. Psychol Health 1994;9:233-52.

Hobfoll SE, Jackson AP, Lavin J, Britton PJ, Shepherd JB. Reducing inner-city women's AIDS risk activities: A study of single, pregnant women. Health Psychol 1994;13:397-403.

Holtgrave DR, Kelly JA. Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. Am J Public Health 1996;86:1442-5.

Jemmott III JB, Jemmott LS, Fong GT. Reducing HIV risk-associated sexual behavior among African-American adolescents: testing the generality of intervention effects. Princeton, NJ: Princeton University Department of Psychology; 1996.

Jonsen AR, Stryker J, editors. The social impact of AIDS in the United States. Washington, DC: National Academy Press; 1993.

Kann L, Warren CW, Harris WA, Collins JL, Williams BI, Ross JG, Kolbe LJ. Youth risk behavior surveillance-United States, 1995. MMWR Morb Mortal Wkly Rep 1996;45 (SS-4):1-84.

Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Deficiency Syndr 1995;10:175-6.

Karon JM, Rosenberg PS, McQuillan G, et al. Prevalence of HIV infection in the United States, 1984-1992. JAMA 1996;276:126-31.

Kegeles SD, Hays RB, Coates TJ. The M-Powerment project: a community-level HIV prevention intervention for young gay men. Am J Public Health 1996;86,1129-36.

Kelly JA, Murphy DA, Washington CD, Wilson TS, Koob JJ, Davis DR, Ledezma G, Davantes B. The effects of HIV/AIDS intervention groups for high-risk women in urban clinics. Am J Public Health 1994;84 (12):1918-22.

Kelly JA, St. Lawrence JS, Stevenson LY, Hauth AC, Kalichman SC, Diaz YE, Brasfield TL, Koob JJ, Morgan MG. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health 1992;82:1483-9.

Koester SK. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drug users. Human Organization 1994;53(3):287-95.

Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors and viral interactions. Epidemiol Rev 1994;16:418-36.

Levine OS, Vlahov D, Koehler J, et al. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol 1995;142:331-41.

Lurie P, Reingold AL, Bowser B, Chen D, Foley J, Guydish J, Kahn JG, Lane S, Sorensen J. The public health impact of needle exchange programs in the United States and abroad. Vol. l. San Francisco: University of California;1993.

Lurie P, Reingold AL, Bowser B, Chen D, Foley J, Guydish J, Kahn JG, Lane S, Sorensen J. The public health impact of needle exchange programs in the United States and abroad: summary, conclusions, and recommendations. Rockville, MD: CDC National AIDS Clearinghouse;1993.

Mandel W, Vlahov D, Latkin C, et al. Correlates of needle sharing among injection drug users. Am J Public Health 1994;849:920-3.

Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, DePhillippis D, Stolley P, Abrutyn E. Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993;1049-56.

Miller HG, Turner CF, Moses LE, editors. AIDS: the second decade. Washington, DC: National Academy Press; 1990. p. 359-472.

Miller, H. G., Turner, G. G., & Moses, L. E. (Eds.). (1993). AIDS: The second decade. Washington, DC: National Academy Press.

National Commission on Acquired Immune Deficiency Syndrome. The twin. National Commission on Acquired Immune Deficiency Syndrome; 1991.

Needle R, Weatherby N, Chitwood D, Booth R, Watters J, Fisher DG, Brown B, Cesari H, Williams ML, Andersen M, Braunstein M. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav 1995;9:242-50.

Nelson KE, Celentano D, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996;335:297-303.

Nicolosi A, Correa Leite ML, Musicco M, et al. Parental and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol 1992;135:225-33.

Normand J, Vlahov D, Moses LE. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press; 1995.

Patrick DM, Strathdee SA, Offner M, et al. Explaining an outbreak: determinants of HIV seroconversion among injecting drug users in Vancouver. Paper presented at: XI International Conference on AIDS; 1996 Jul 9; Vancouver, Canada.

Peterson JL, Coates TJ, Catania J, Hauck WW, Acree M, Daigle D, Hillard B, Middleton L, Hearst N. Evaluation of an HIV risk reduction intervention among African American homosexual and bisexual men. AIDS 1996;10:319-25.

Quinn TC. Global burden of the HIV pandemic. Lancet 1996;348:99-106.

Rhodes F, Malotte CK. HIV risk interventions for active drug users: experience and prospects. In: Oskamp S, Thompson SC, editors. Understanding and preventing HIV risk behavior. Thousand Oaks, CA: Sage Publications; 1996.

Rosenstock IM, Strecher VJ, Becker MH. The health belief model and HIV risk behavior change. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum; 1994. p. 5-24.

Rotheram-Borus MJ, Koopman C, Haignere C, Davies M. Reducing HIV sexual risk behaviors among runaway adolescents. JAMA 1991;266:1237-41.

Selwyn PA, Feiner C, Cox CP, et al. Knowledge about AIDS and high risk behaviors among intravenous drug users in New York City. AIDS 1987;1:247-54.

Serpelloni G, Carriere MP, Rezza G, Morganti S, Gomma M, Binkin N. (1994). Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-controlled study. AIDS Care 1994;6:215-20.

St. Lawrence J, Brasfield T, Jefferson K, Alleyne E, O'Brannon III RA, Shirley A. Cognitive behavioral intervention to reduce African-American adolescents' risk for HIV infection. J Consul Clin Psychol 1995;63:221-37.

Stephens RC, Simpson DD, Coyle SL, McCoy CB, National AIDS Research Consortium. Comparative effectiveness of NADR interventions. In: Brown BS, Beschner GM, editors, Handbook on risk of AIDS. Westport, CT: Greenwood Press; 1993.

Stimson GV, et al. Injecting equipment exchange schemes: final report. London: The Centre for Drugs and Health Behaviors; 1988.

Stryker J, Coates TJ, DeCarlo P, et al. Prevention of HIV infection: looking back, looking ahead. JAMA 1995;273:1143-8.

Susser E. Editorial: the tribulations of trials-intervention in community. Am J Public Health 1995;85(2):156-8.

Susser M. Judgment and causal inference: criteria in epidemiologic studies. Am J Epidemiol 1977;105:1-15. [Reprinted in Am J Epidemiol 141, 701-15.]

Susser M. The logic in ecological: I. The logic of analysis. Am J Public Health 1994;84(5):825-9.

Susser M. The logic in ecological: II. The logic of design. Am J Public Health 1994;84(5):830-5.

Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol 1991;133(7):635-48.

Susser M, Valencia E, Conover S, Felix A, Tsai W-Y, Wyatt RJ. Prevention of recurrent homelessness among mentally ill men: a randomized clinical trial of a critical time intervention. Am J Public Health. In press.

Sweat M, Dennison J. Reducing HIV incidence in developing countries with structural and environmental interventions. AIDS 1995;9 (Suppl. A):S225-57.

Tawil O, Verster A, O'Reilly K. Enabling approaches for HIV/AIDS prevention: can we modify the environment and minimize the risk? AIDS 1995;9:1299-306.

Turner CF, Miller HG, Moses LE, editors. AIDS: sexual behavior and intravenous drug use. Washington, DC: National Academy Press; 1989.

U.S. General Accounting Office. Needle exchange programs: research suggests promise as an AIDS prevention strategy. Report Number GAO/HRD-93-60. Washington, DC: U. S. Government Printing Office; 1993.

U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. HIV/AIDS Surveillance Reports, Vol. 7, No. 2 year-end edition, 1995, and Vol. 8, No. 1, midyear edition, 1996.

U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. First 500,000 AIDS cases-United States, 1995. MMWR Morb Mortal Weekly Rep 44, 46, Nov. 24, 1995.

Valdiserri RO, Lyter D, Levitron L, Callahan C, Kingsley LA, Rinaldo C. (1989). AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS 1989;3:21-6.

Walter HJ, Vaughan RD. AIDS risk reduction among a multiethnic sample of urban high school students. JAMA 1993;270:725-30.

Watters J K, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug uses. JAMA 1994;271(2):115-20.

WHO/GPA/IDS. Effective approaches to AIDS prevention. Report of a meeting; 1992 May 26-29; Geneva. WHO/GPA/IDS/93.1.

Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:282-9.

Back
Table of Contents